Showing results (181-190 of 312) with videos related to
Sort By:
Pageof 32
American Journal of Public Health|April 1, 1988
Geographic distribution of human immunodeficiency virus markers in parenteral drug abusersW R Lange, F R Snyder, D Lozovsky, et al.Journal of Clinical Psychopharmacology|April 1, 1984
Dexamethasone suppression test in recently detoxified alcoholics: clinical implicationsA Khan, D A Ciraulo, W H Nelson, et al.Proceedings of the National Academy of Sciences of the United States of America|August 1, 1992
A high-molecular-weight squid neurofilament protein contains a lamin-like rod domain and a tail domain with Lys-Ser-Pro repeatsJ Way, M R Hellmich, H Jaffe, et al.Neurology|June 14, 2006
Tau protein hyperphosphorylation in sporadic ALS with cognitive impairmentM J Strong, W Yang, W L Strong, et al.Pflugers Archiv : European Journal of Physiology|November 23, 2006
Depolymerisation and rearrangement of actin filaments during exocytosis in rat peritoneal mast cells: involvement of ryanodine-sensitive calcium storesR E Guzmán, P Bolaños, A Delgado, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1988
Kaposi's sarcoma involving the lung in patients with the acquired immunodeficiency syndromeL D Kaplan, P C Hopewell, H Jaffe, et al.Journal of Substance Abuse Treatment|December 23, 2018
Initiating methadone in jail and in the community: Patient differences and implications of methadone treatment for reducing arrestsRobert P Schwartz, Sharon M Kelly, Shannon Gwin Mitchell, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Differential effects of the cytoplasmic domains of cell adhesion molecules on cell aggregation and sorting-outS H Jaffe, D R Friedlander, F Matsuzaki, et al.Journal of Substance Abuse Treatment|November 19, 2013
Leaving buprenorphine treatment: patients' reasons for cessation of careJan Gryczynski, Shannon Gwin Mitchell, Jerome H Jaffe, et al.Journal of Substance Abuse Treatment|November 19, 2013
Interim versus standard methadone treatment: a benefit-cost analysisRobert P Schwartz, Pierre K Alexandre, Sharon M Kelly, et al.Pageof 32